Amicus Therapeutics(FOLD) - 2023 Q3 - Earnings Call Transcript

Amicus Therapeutics Inc. (NASDAQ:FOLD) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Andrew Faughnan - Vice President, Investor Relations Bradley Campbell - President, Chief Executive Officer Sebastien Martel - Chief Business Officer Simon Harford - Chief Financial Officer Jeff Castelli - Chief Development Officer Mitchell Goldman - Chief Medical Officer Ellen Rosenberg - Chief Legal Officer Mike Kaveney - President of U.S. Commercial Business and Head of Global Marketing ...